BEDFORD, Mass. and SAN DIEGO,– Hologic, Inc. (NASDAQ: HOLX) and Gen-Probe Incorporated (NASDAQ: GPRO) today announced that their Boards of Directors have unanimously approved a definitive agreement under which Hologic will acquire all of the outstanding shares of Gen-Probe for $82.75 per share in cash, or a total enterprise value of approximately $3.7 billion. The […]
PIUG 2012 Annual Conference – Denver, Colo – Questel, a leader in online information services for over 40 years, and GenomeQuest, a global provider of large-scale genomic software applications, announced today a partnership to integrate the two companies’ platforms for researching and managing global IP. Specifically, GQ-IP users will now have the option to review […]
LAKE FOREST, Ill — IDEX Corporation (NYSE: IEX) announced today that it has acquired ERC from MH Capital Partners II, L.P. (“MH Capital”). ERC is a leader in the manufacture of gas liquid separations and detection solutions for the life science, analytical instrumentation and clinical chemistry markets. ERC’s pioneering products include in-line membrane vacuum degassing […]
PORT WASHINGTON, N.Y.,- Pall Corporation (NYSE:PLL) today announced it has entered into an agreement to sell certain assets of its blood collection, filtration and processing product lines to Haemonetics Corporation (NYSE:HAE) for approximately $550 million. Assets included in the transaction are Pall’s portfolio of blood collection, processing and filtration systems and equipment for transfusion medicine. […]
Hyderabad, Andhra Pradesh, India,: Ocimum Biosolutions announced an expansion of the BioIT business in Malaysia through a joint venture with a Malaysian company. The new venture, known as Ocimum Biotech Asia sdn. bhd., started operations in April 2012. Malaysia is seen as a gateway for Ocimum products and services to address the ASEAN markets. Over […]
RADNOR, PA, – VWR International, LLC, a global leader in distributing laboratory supplies and services, announced today that it has signed an agreement to acquire basan Germany GmbH, including its subsidiaries and operations in The Netherlands, France, Italy, Singapore, Malaysia and Vietnam. The agreement is subject to customary closing conditions and regulatory approval in Germany. […]
London, UK, Boston, US, – IDBS, a global provider of innovative enterprise data management, analytics and modeling solutions, today announced a partnership with the Intellectual Property & Science division of Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals, to transform how researchers access curated biological content and apply it to […]
SOUTH EASTON, Mass., — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI”) and Target Discovery, Inc. (“TDI”), (together “the companies”), today announced the signing of expanded strategic technology license and supply agreements (the “Agreements”). Under these agreements, TDI now has the right to use PBI’s patented and enabling Pressure Cycling Technology (“PCT”) Platform for their planned entry […]
IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp’s products and intellectual property assets to expand its consumables offering and to accelerate the commercialization […]
ALAMEDA, Calif. & CAMBRIDGE, Mass.,–BioTime, Inc. (NYSE Amex:BTX) and its wholly owned subsidiary LifeMap Sciences today announced that they have signed a definitive agreement to acquire XenneX, Inc. through a merger of XenneX into LifeMap Sciences. The acquisition is expected to close within thirty days. XenneX holds the exclusive, worldwide licenses to market GeneCards(R) and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
